Primary Cutaneous T-cell Lymphoma
2 clinical trials · Condition
◉ Watch Primary Cutaneous T-cell Lymphoma
| Record | Firm | Date |
|---|---|---|
| Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin Lymphoma (NCT04234048) | SciTech Development, Inc. | 2023-12-18 |
| A Registry for People With T-cell Lymphoma (NCT05978141) | Memorial Sloan Kettering Cancer Center | 2023-07-27 |
Track Primary Cutaneous T-cell Lymphoma automatically
Every clearance here is in the API, with alerts when new ones post.